insights_auto
Why is EDIT down 3.75%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$2.57
arrow_downward
-3.75%(-0.10) 1D
$2.59
arrow_upward
+0.78% (+0.020)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.71
High
$2.78
Low
$2.55
Mkt. cap
394.70M
Avg. vol.
2.50M
Volume
1.24M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
Open
$2.71
High
$2.78
Low
$2.55
Mkt. cap
394.70M
Avg. vol.
2.50M
Volume
1.24M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
Yardeni Says Analysts Still See S&P 500 Earnings Near $500 Per Share by 2028
Traders Union
·
5 hours ago
JOJO.Index outperformed long Treasuries with 6.26% return in August 2024, Michael A. Gayed notes
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc